Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Love Pharma appoints Joshua Maurice as chief operating officer

The new executive joins the company after spending four years at Callitas Therapeutics—during which time he quickly rose through the ranks from director of sales & marketing to VP of sales & business development and then to president

Love Pharma Co, an international sexual health, wellness, and psychedelics company, said it has appointed marketing, development and sales executive, Joshua Maurice to the role of chief operating officer.

Maurice, who has two decades of experience, will oversee the day-to-day operations at the emerging sexual health, wellness and psychedelics company.

The new executive joins the company after spending four years at Callitas Therapeutics—during which time he quickly rose through the ranks from director of sales & marketing to VP of sales & business development and then to president.

READ: Love Pharma announces name change as it completes the acquisition of Kick Pharmaceuticals

Throughout his tenured career, Maurice has gained experience in consumer goods with a focus on the development of over-the-counter drug and nutraceuticals, including efficacy, clinical research, branding, marketing, advertising, and global retail distribution.

“Joshua’s expertise is exactly what we need to properly execute the rollout of new products as well as to oversee the distribution and marketing of our strong portfolio of therapeutic and pharmaceutical products,” Zachary Stadnyk, Love Pharma (CSE:LUV)’s CEO and director, said in a statement.

Stadnyk added; “We welcome Joshua—a talented senior executive with years of experience—to the Love Pharma team, where his guidance and history will make him an invaluable asset; and we look forward to the future growth and rapid expansion that he will lead.”

The company also outlined the responsibilities Maurice would assume in is new role, including:

  • Overseeing day-to-day operations, including logistics and supply chain systems;
  • Directing the acquisition of new technologies as well as product development;
  • Steering the launch of new products—including key branded products such as BLOO and AURALIEF— and their respective marketing and advertising campaigns; and
  • Leading contract negotiations and vendor acquisitions

“While I am truly impressed by the breadth of the Love Pharma portfolio—ranging from CBD and psychedelics to sexual wellness and conception—it’s being ideally positioned to bring novel health and wellness products to market that really excites me about joining the Love Pharma team; and I look forward to focusing on how our innovative technologies can legitimately improve the lives of our customers,” Maurice said.

Contact the writer at georgia@proactiveinvestors.com

Follow her on Twitter @MissInformd

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK